| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 292 | $83.49 | $24,379.08 | -0.1% | -30.0% | -67.1% | |
| Jan 3, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 29,167 | $88.27 | $2,574,563.93 | -8.0% | -51.2% | -57.9% | |
| Jan 3, 2022 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 50,189 | $217.02 | $10,892,117.30 | -0.3% | -22.0% | -2.8% | |
| Jan 3, 2022 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 50,189 | $217.02 | $10,892,117.30 | -0.3% | -22.0% | -2.8% | |
| Dec 30, 2021 | BDSX Biodesix Inc | Patience John | Director, 10% Owner, Chairman | Buy | 160,919 | $4.35 | $699,997.65 | +8.2% | -60.8% | -47.8% | |
| Dec 30, 2021 | BDSX Biodesix Inc | Strobeck Matthew | Director | Buy | 147,800 | $4.35 | $642,930.00 | +177.4% | -60.8% | -47.8% | |
| Dec 30, 2021 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 2,298,850 | $4.35 | $9,999,997.50 | +37.3% | -60.8% | -47.8% | |
| Dec 29, 2021 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 3,669 | $161.00 | $590,709.00 | -4.1% | -13.7% | -5.4% | |
| Dec 29, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 5,994 | $75.62 | $453,266.28 | -11.9% | -32.3% | -68.9% | |
| Dec 29, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 40,868 | $221.35 | $9,046,217.24 | -0.4% | -24.8% | -2.2% | |
| Dec 29, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 40,868 | $221.35 | $9,046,217.24 | -0.4% | -24.8% | -2.2% | |
| Dec 28, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 1,382 | $91.34 | $126,231.74 | -5.7% | -55.4% | -55.9% | |
| Dec 28, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 914 | $91.34 | $83,484.67 | -1.3% | -55.4% | -55.9% | |
| Dec 28, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 685 | $91.34 | $62,567.83 | -1.2% | -55.4% | -55.9% | |
| Dec 28, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,604 | $91.34 | $237,849.10 | -5.4% | -55.4% | -55.9% | |
| Dec 28, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 202 | $91.34 | $18,450.66 | - | -55.4% | -55.9% | |
| Dec 27, 2021 | TWST Twist Bioscience Corp | Leproust Emily M.77 | President &CEO | Sell | 5,300 | $80.90 | $428,779.61 | -0.7% | -41.4% | -72.7% | |
| Dec 27, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 62,001 | $225.03 | $13,952,382.51 | -0.6% | -29.9% | -8.5% | |
| Dec 27, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 62,001 | $225.03 | $13,952,382.51 | -0.6% | -29.9% | -8.5% | |
| Dec 23, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 429 | $93.00 | $39,895.31 | -0.3% | -58.6% | -55.7% | |
| Dec 23, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 204 | $92.99 | $18,969.96 | - | -58.6% | -55.7% | |
| Dec 23, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,657 | $93.00 | $154,096.85 | -1.9% | -58.6% | -55.7% | |
| Dec 23, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 447 | $93.00 | $41,569.13 | -0.4% | -58.6% | -55.7% | |
| Dec 22, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 5,994 | $85.09 | $510,029.46 | -13.6% | -42.6% | -72.6% | |
| Dec 22, 2021 | IQV Iqvia Holdings Inc. | Danhakl John G60 | Director | Buy | 10,000 | $272.93 | $2,729,300.00 | +69.7% | -17.3% | -26.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.